Immunologist William Murphy discusses CAR T-cell cancer therapy and his work with Caring Cross, CIRM and UC Davis researchers to find novel cures to leukemia and lymphoma.
Read MoreCIRM awarded UC Davis’ Alpha Stem Cell Clinic an $8 million grant renewal to expand its successful clinical trials operation and advance toward onsite manufacturing of therapies.
Read MoreMichelle and Jeff were excited to build their new family together, but when she received the distressing news that her developing baby was diagnosed with spina bifida, she looked for the best treatment. She was referred to the CuRe trial.
Read MoreThree babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele.”
Read MoreCardiothoracic surgery resident Nataliya Bahatyrevich has become the latest UC Davis trainee to receive a prestigious T32 federal research grant. The award will allow her to spend a year in the laboratory and pursue a Master of Science in biomedical engineering at UC Davis
Read MoreStem cell researcher Jan Nolta received the Lifetime Achievement Award in Innovation during the 2022 Chancellor’s Innovation Awards ceremony on June 16. The awards recognize faculty, community partners and industry leaders developing innovative solutions to improve the lives of others and address important needs in the global society.
Read MoreProfessor Aijun Wang won $3 million grant from California Institute for Regenerative Medicine to develop a smart durable vascular device for hemodialysis patients treated for kidney failure. The device uses a unique molecule to help prevent synthetic vascular graft failure, a common problem for patients undergoing hemodialysis.
Read MoreThe UC Davis MIND Institute is launching a $4 million research program aimed at finding transformative therapies for ADNP syndrome, a rare genetic condition. A group of interdisciplinary researchers will evaluate multiple gene therapies for possible use.
Read MoreIn a first of its kind clinical trial led by UC Davis Health, HOPE-2 showed that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
Read More